Klaus Zöphel

Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer

Daniel Zips, Klaus Zöphel, Nasreddin Abolmaali et al. · Radiotherapy and Oncology · 2012 · 283 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling

Stefan Leger, Alex Zwanenburg, K. Pilz et al. · Scientific Reports · 2017 · 229 citations · Full text

Public Health, Biostatistics, Oncology +17

Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging

Steffen Löck, Rosalind Perrin, Annekatrin Seidlitz et al. · Radiotherapy and Oncology · 2017 · 146 citations

Medicine, Nuclear Medicine, Oncology +17

Retinoic acid for redifferentiation of thyroid cancer--does it hold its promise?

Thomas Grüning, Claudia Tiepolt, Klaus Zöphel et al. · European Journal of Endocrinology · 2003 · 126 citations

Medicine, Nuclear Medicine, Oncology +17

Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer

M. Hentschel, Steffen Appold, Andreas Schreiber et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 112 citations

Medicine, Oncology, Radiation Oncology +7